Document:

Exhibit
10.9

 

TERAWULF

2021 Omnibus Incentive Plan

 

1.            Purpose.
The purpose of the TeraWulf 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) is to (i) attract
and retain individuals to serve as employees, consultants or Directors of TeraWulf Inc., a Delaware corporation (together with its Subsidiaries,
whether existing or thereafter acquired or formed, and any and all successor entities, the “Company”) and its
Affiliates by providing them the opportunity to acquire an equity interest in the Company or other incentive compensation and (ii) align
the interests of the foregoing with those of the Company’s stockholders.

 

2.            Effective Date; Duration. The effective date of the Plan is May 13, 2021 (the “Effective Date”),
which is the date that the Plan was approved by the stockholders of the Company. The expiration date of the Plan, on and after which date
no Awards may be granted under the Plan, shall be the 10th anniversary of the Effective Date (the “Expiration Date”);
provided, however, that such expiration shall not affect Awards then outstanding, and the terms and conditions of the Plan
shall continue to apply to such Awards.

 

3.            Definitions.
The following definitions shall apply throughout the Plan:

 

(a)           “Affiliate” means (i) any person or entity that directly or indirectly controls, is controlled by
or is under common control with the Company and/or (ii) to the extent provided by the Committee, any person or entity in which the
Company has a significant interest. The term “control” (including, with correlative meaning, the terms “controlled by”
and “under common control with”), as applied to any person or entity, means the possession, directly or indirectly, of the
power to direct or cause the direction of the management and policies of such person or entity, whether through the ownership of voting
or other securities, by contract or otherwise.

 

(b)           “Award” means, individually or collectively, any Incentive Stock Option, Nonqualified Stock Option, Stock
Appreciation Right, Restricted Stock, Restricted Stock Unit, Other Stock-Based Award or Other Cash-Based Award granted under the Plan.

 

(c)           “Award Agreement” means any agreement (whether in written or electronic form) or other instrument or
document evidencing any Award (other than an Other Cash-Based Award) granted under the Plan (including, in each case, in electronic form),
which may, but need not, be executed or acknowledged by a Participant (as determined by the Committee).

 

(d)           “Beneficial
Ownership” has the meaning set forth in Rule 13d-3 promulgated under Section 13 of the Exchange Act.

 

(e)           “Board” means the Board of Directors of the Company.

 

(f)            “Cause”
means, with respect to any Participant, “cause” as defined in such Participant’s Employment Agreement, if any, or if
not so defined, except as otherwise provided in such Participant’s Award Agreement, such Participant’s: (i) having engaged
in material misconduct in providing services to the Company or its Affiliates; (ii) having engaged in conduct that he or she knew
or reasonably should have known would be materially injurious to the Company or its Affiliates; (iii) having been convicted of,
or having entered a plea bargain or settlement admitting guilt for, (x) a felony or (y) any other criminal offense involving
moral turpitude, fraud or, in the course of the performance of the Participant’s service to the Company, material dishonesty; (iv) unlawful
use or possession of illegal drugs on the Company’s premises or while performing the Participant’s duties and responsibilities
to the Company; or (v) commission of an act of fraud, embezzlement or misappropriation, in each case against the Company or any
Affiliate. The determination of whether Cause exists shall be made by the Committee in good faith in its sole discretion upon, or within
60 days following, termination of the Participant’s employment or service based on information available to the Committee through
such 60-day period. Notwithstanding the foregoing, Cause shall not exist unless the Participant has first received a written notice from
the Company which sets forth in reasonable detail the circumstances giving rise to Cause and the Participant shall have a period of 30
days to cure (if capable of cure).

 

     

     

    

 

(g)           “Change in Control” means, unless the applicable Award Agreement or the Committee provides otherwise,
the first to occur of any of the following events:

 

(i)               
the acquisition by any Person or related “group” (as such term is used in Section 13(d) and Section 14(d)
of the Exchange Act) of Persons, or Persons acting jointly or in concert, of Beneficial Ownership (including control or direction) of
50% or more (on a fully diluted basis) of either (A) the then-outstanding Shares, including Shares issuable upon the exercise of
options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such Shares or (B) the
combined voting power of the then-outstanding voting securities of the Company entitled to vote in the election of Directors (the “Outstanding
Company Voting Securities”), but excluding any acquisition by the Company or any of its Affiliates, its Permitted Transferees
or any of their respective Affiliates or by any employee benefit plan sponsored or maintained by the Company or any of its Affiliates;

 

(ii)              
a change in the composition of the Board such that members of the Board during any consecutive 24-month period (the “Incumbent
Directors”) cease to constitute a majority of the Board. Any person becoming a Director through election or nomination for
election approved by a valid vote of at least two-thirds of the Incumbent Directors shall be deemed an Incumbent Director; provided,
however, that no individual becoming a Director as a result of an actual or threatened election contest, as such terms are used
in Rule 14a-12 of Regulation 14A promulgated under the Exchange Act, or as a result of any other actual or threatened solicitation of
proxies or consents by or on behalf of any person other than the Board, shall be deemed an Incumbent Director;

 

(iii)             
the approval by the stockholders of the Company of a plan of complete dissolution or liquidation of the Company; or

 

(iv)              the
consummation of a reorganization, recapitalization, merger, amalgamation, consolidation, statutory share exchange or similar form of
corporate transaction involving (x) the Company or (y) any of its Subsidiaries, but in the case of this clause (y) only if
Outstanding Company Voting Securities are issued or issuable (a “Business Combination”), or sale, transfer
or other disposition of all or substantially all of the business or assets of the Company to an entity that is not an Affiliate of
the Company (a “Sale”), unless immediately following such Business Combination or Sale: (A) more than
50% of the total voting power of the entity resulting from such Business Combination or the entity that acquired all or
substantially all of the business or assets of the Company in such Sale (in either case, the “Surviving
Company”), or the ultimate parent entity that has Beneficial Ownership of sufficient voting power to elect a majority
of the board of directors (or analogous governing body) of the Surviving Company (the “Parent Company”),
is represented by the Outstanding Company Voting Securities that were outstanding immediately prior to such Business Combination or
Sale (or, if applicable, is represented by Shares into which the Outstanding Company Voting Securities were converted pursuant to
such Business Combination or Sale), and such voting power among the holders thereof is in substantially the same proportion as the
voting power of the Outstanding Company Voting Securities among the holders thereof immediately prior to the Business Combination or
Sale, (B) no Person (other than any employee benefit plan sponsored or maintained by the Surviving Company or the Parent
Company) is or becomes the beneficial owner, directly or indirectly, of 50% or more of the total voting power of the outstanding
voting securities eligible to elect members of the board of directors (or the analogous governing body) of the Parent Company (or,
if there is no Parent Company, the Surviving Company) and (C) at least a majority of the members of the board of directors (or
the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving Company) following the
consummation of the Business Combination or Sale were Board members at the time of the Board’s approval of the execution of
the initial agreement providing for such Business Combination or Sale.

 

    2

     

    

 

(h)           “Code” means the U.S. Internal Revenue Code of 1986, as amended, and any successor thereto. References
to any section of the Code shall be deemed to include any regulations or other interpretative guidance under such section, and any amendments
or successors thereto.

 

(i)            “Committee” means the Compensation Committee of the Board or subcommittee thereof or, if no such committee
or subcommittee thereof exists, or if the Board otherwise takes action hereunder on behalf of the Committee, the Board.

 

(j)            “Common Stock” means the common stock of the Company, par value of $0.001 per share (and any stock or
other securities into which such common stock may be converted or into which it may be exchanged).

 

(k)           “Company” has the meaning set forth in Section 1 of the Plan.

 

(l)            “Director” means any member of the Company’s Board.

 

(m)          “Deferred Award” means an Award granted pursuant to Section 13 of the Plan.

 

(n)           “Detrimental Conduct” means, as determined by the Company, any of the following, which, in each case,
must be materially adverse to the finances, business, reputation, condition, assets or results of operations of the Company or any of
its Affiliates: (a) any violation by the Participant of a restrictive covenant agreement that the Participant has entered into with the
Company or an Affiliate (covering, for example, non-competition, non-solicitation, non-disparagement, non-disclosure of confidential information,
etc.), to the extent permitted by law; (b) any conduct by the Participant that could result in the Participant’s termination
of service with the Company or an Affiliate for Cause; (c) the commission of a criminal act or other improper or intentional conduct
by the Participant, whether or not performed in the workplace, that subjects, or if generally known would subject, the Company or an Affiliate
to public ridicule or embarrassment; (d) the Participant’s breach of a fiduciary duty owed to the Company or an Affiliate or
a client or former client of the Company or an Affiliate; (e) the Participant’s intentional violation, or grossly negligent
disregard, of the Company’s or an Affiliate’s policies, rules or procedures; or (f) the Participant taking or maintaining
trading positions that result in a need to restate financial results in a subsequent reporting period or that result in a significant
financial loss to the Company or an Affiliate.

 

(o)           “Disability” means, unless otherwise provided in an Award Agreement, a determination that a Participant
is disabled in accordance with a long-term disability insurance program maintained by the Company or a determination by the U.S. Social
Security Administration that the Participant is totally disabled.

 

(p)           “dollar” or “$” shall refer to United States dollars.

 

(q)           “Effective Date” has the meaning set forth in Section 2 of the Plan.

 

    3

     

    

 

(r)            “Eligible Director” means a Director who satisfies the conditions set forth in Section 4(a) of the Plan.

 

(s)           “Eligible
Person” means any (i) individual employed by the Company or an Affiliate, (ii) Director or officer of the Company
or an Affiliate, (iii) consultant or advisor to the Company or an Affiliate who may be offered securities registrable on Form S-8
under the Securities Act, or (iv) prospective employee, director, officer, consultant or advisor who has accepted an offer of employment
or service from the Company or an Affiliate (and would satisfy the provisions of clause (i), (ii) or (iii) above once such individual
begins employment with or providing services to the Company or an Affiliate).

 

(t)            “Employment Agreement” means any employment, severance, consulting or similar agreement (including any
offer letter) between the Company or an Affiliate and a Participant.

 

(u)           “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and any successor thereto.
References to any section of (or rule promulgated under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative
guidance under such section or rule, and any amendments or successors thereto.

 

(v)           “Expiration
Date” has the meaning set forth in Section 2 of the Plan.

 

(w)          “Fair Market Value” means, (i) with respect to a Share on a given date, (x) if the Shares are
listed on a national securities exchange, the closing sales price of a Share reported on such exchange on such date or, if there is no
such sale on that date, then on the last preceding date on which such a sale was reported or (y) if the Shares are not listed on
any national securities exchange, the amount determined by the Committee in good faith to be the fair market value of a Share or (ii) with
respect to any other property on any given date, the amount determined by the Committee in good faith to be the fair market value of such
other property as of such date; provided, however, as to any Awards granted on or with a date of grant of the pricing of
the Company’s initial public offering (if any), “Fair Market Value” shall be equal to the per Share price offered to
the public in connection with such initial public offering.

 

(x)           “Good
Reason” means “good reason” as defined in a Participant’s Employment Agreement, Award Agreement or the
Company’s severance plan in which such Participant participates, if any; provided, that if such agreements or plans do not contain
a definition of “good reason” applicable to such Participant, then Good Reason shall be disregarded with respect to the applicable
Participant for purposes of this Plan and any Award.

 

(y)           “Immediate Family Members” has the meaning set forth in Section 15(b)(ii) of the Plan.

 

(z)           “Incentive Stock Option” means an Option that is designated by the Committee as an incentive stock option
as described in Section 422 of the Code and otherwise meets the requirements set forth in the Plan.

 

(aa)         “Intrinsic
Value” with respect to an Option or SAR means (i) the excess, if any, of the price or implied price per Share in a
Change in Control or other event over (ii) the exercise or hurdle price of such Award multiplied by (iii) the number of Shares
covered by such Award.

 

(bb)        “Indemnifiable Person” has the meaning set forth in Section 4(e) of the Plan.

 

(cc)         “NASDAQ”
means Nasdaq Global Market.

 

    4

     

    

 

(dd)         “Nonqualified Stock Option” means an Option that is not designated by the Committee as an Incentive
Stock Option.

 

(ee)         “Option” means an Award granted under Section 7 of the Plan.

 

(ff)          “Option
Period” has the meaning set forth in Section 7 of the Plan.

 

(gg)        “Other Cash-Based Award” means an Award granted under Section 10 of the Plan that is denominated
and/or payable in cash, including cash awarded as a bonus or upon the attainment of specific performance criteria or as otherwise permitted
by the Plan or as contemplated by the Committee.

 

(hh)        “Other Stock-Based Award” means an Award granted under Section 10 of the Plan.

 

(ii)           “Participant”
has the meaning set forth in Section 6 of the Plan.

 

(jj)           “Permitted Transferee” has the meaning set forth in Section 15(b)(ii) of the Plan.

 

(kk)         “Person” has the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d)
and 14(d) thereof, except that such term shall not include (i) the Company or any of its Affiliates, (ii) a trustee or other
fiduciary holding securities under an employee benefit plan of the Company or any of its Affiliates, (iii) an underwriter temporarily
holding securities pursuant to an offering of such securities or (iv) a corporation owned, directly or indirectly, by the stockholders
of the Company in substantially the same proportions as their ownership of Shares of the Company.

 

(ll)           
“Released Unit” has the meaning set forth in Section 9(g)(ii) of the Plan.

 

(mm)       “Restricted Period” has the meaning set forth in Section 9(a) of the Plan.

 

(nn)        “Restricted Stock” means any Share subject to certain specified restrictions and forfeiture conditions,
granted pursuant to Section 9 of the Plan.

 

(oo)        “Restricted
Stock Unit” means a contractual right granted pursuant to Section 9 of the Plan that is denominated in Shares. Each Restricted
Stock Unit represents an unfunded and unsecured promise to deliver Shares, cash, other securities or other property, or a combination
thereof, subject to certain specified restrictions, granted pursuant to Section 9 of the Plan.

 

(pp)        “SAR Period” has the meaning set forth in Section 8(c) of the Plan.

 

(qq)        “Securities Act” means the U.S. Securities Act of 1933, as amended, and any successor thereto. Reference
in the Plan to any section of (or rule promulgated under) the Securities Act shall be deemed to include any rules, regulations or other
interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or
other interpretive guidance.

 

(rr)          “Share”
means a share of Common Stock, par value of $0.001 per share.

 

(ss)         “Stock
Appreciation Right” or “SAR” means an Award granted under Section 8 of the Plan.

 

(tt)           “Subsidiary”
means (i) any corporation or other entity a majority of whose outstanding voting stock or voting power is beneficially owned directly
or indirectly by the Company and (ii) any other entity which the Committee determines should be treated as a “Subsidiary.”

 

    5

     

    

 

(uu)         “Substitute
Award” means an Award granted under the Plan upon the assumption of, or in substitution for, outstanding equity awards
previously granted by a company or other entity in connection with a corporate transaction, such as a merger, combination, consolidation
or acquisition of property or stock; provided, however, that in no event shall the term “Substitute Award”
be construed to refer to an award made in connection with the cancellation and repricing of an Option or Stock Appreciation Right.

 

4.            Administration.

 

(a)            Authority
of the Committee. The Committee shall administer the Plan, and shall have the sole and plenary authority to (i) designate Participants,
(ii) determine the type, size, and terms and conditions of Awards to be granted and to grant such Awards (including Substitute Awards),
(iii) determine the method by which an Award may be settled, exercised, canceled, forfeited, suspended or repurchased by the Company,
(iv) determine the circumstances under which the delivery of cash, property or other amounts payable with respect to an Award may
be deferred, either automatically or at the Participant’s or Committee’s election, (v) interpret, administer, reconcile
any inconsistency in, correct any defect in and supply any omission in the Plan and any Award granted under the Plan, (vi) establish,
amend, suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper administration
of the Plan, (vii) accelerate or modify the vesting, delivery or exercisability of, or payment for or lapse of restrictions on,
or waive any condition in respect of, Awards and (viii) make any other determination and take any other action that the Committee
deems necessary or desirable for the administration of the Plan or to comply with any applicable law. To the extent determined by the
Board and/or required to comply with the provisions of Rule 16b-3 promulgated under the Exchange Act (if applicable and if the Board
is not acting as the Committee under the Plan), or any exception or exemption under applicable securities laws or the applicable rules
of the NASDAQ or any other securities exchange or inter-dealer quotation service on which the Shares are listed or quoted, as applicable,
it is intended that each member of the Committee shall, at the time such member takes any action with respect to an Award under the Plan,
be (1) a “non-employee director” within the meaning of Rule 16b-3 promulgated under the Exchange Act and/or (2) an
 “independent director” under the rules of the NASDAQ or any other securities exchange or inter-dealer quotation service on
which the Shares are listed or quoted, or a person meeting any similar requirement under any successor rule or regulation (“Eligible
Director”). However, the fact that a Committee member shall fail to qualify as an Eligible Director shall not invalidate
any Award granted or action taken by the Committee that is otherwise validly granted or taken under the Plan.

 

(b)           Delegation.
The Committee may delegate all or any portion of its responsibilities and powers to any person(s) selected by it, except for grants of
Awards to persons who are members of the Board or are otherwise subject to Section 16 of the Exchange Act. To the extent permitted
by applicable law, including under Section 157(c) of the Delaware General Corporation Law, the Committee may delegate to one or
more officers of the Company the authority to grant Options, SARs, Restricted Stock Units or other Awards in the form of rights to Shares,
except that such delegation shall not be applicable to any Award for a Person then covered by Section 16 of the Exchange Act, and
the Committee may delegate to one or more committees of the Board (which may consist of solely one Director) the authority to grant all
types of awards, in accordance with applicable law. Any such delegation may be revoked by the Committee at any time. At all times through
the occurrence of the Company’s initial public offering, or the consummation of a merger or other transaction that results in a
listing of the Company’s Shares on the NASDAQ or another securities exchange, the Company’s chief executive officer shall
be delegated the authority to grant Options, SARs, Restricted Stock Units or other Awards in the form of rights to Shares with respect
to up to the full Share Pool.

 

(c)            International
Participants. As further set forth in Section 15(g) of the Plan, the Committee shall have the authority to amend the Plan
and Awards to the extent necessary to permit participation in the Plan by Eligible Persons who are located outside of the United
States or are subject to laws outside of the United States on terms and conditions comparable to those afforded to Eligible Persons
located within the United States; provided, however, that no such action shall be taken without stockholder approval
if such approval is required by applicable securities laws or regulations or NASDAQ listing guidelines.

 

    6

     

    

 

(d)           Decisions
Binding. Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions
regarding the Plan or any Award or any documents evidencing Awards granted pursuant to the Plan shall be within the sole discretion of
the Committee, may be made at any time and shall be final, conclusive and binding upon all persons and entities, including, without limitation,
the Company, any Affiliate, any Participant, any holder or beneficiary of any Award and any stockholder of the Company.

 

(e)           Limitation of Liability. No member of the Board or the Committee, nor any employee (including, the Company’s chief
executive officer) or agent of the Company (each such person, an “Indemnifiable Person”), shall be liable for
any action taken or omitted to be taken or any determination made with respect to the Plan or any Award hereunder (unless constituting
fraud or a willful criminal act or willful criminal omission). Each Indemnifiable Person shall be indemnified and held harmless by the
Company against and from any loss, cost, liability or expense (including attorneys’ fees) that may be imposed upon or incurred by
such Indemnifiable Person in connection with or resulting from any action, suit or proceeding to which such Indemnifiable Person may be
involved as a party, witness or otherwise by reason of any action taken or omitted to be taken or determination made under the Plan or
any Award Agreement and against and from any and all amounts paid by such Indemnifiable Person with the Company’s approval (not
to be unreasonably withheld), in settlement thereof, or paid by such Indemnifiable Person in satisfaction of any judgment in any such
action, suit or proceeding against such Indemnifiable Person, and the Company shall advance to such Indemnifiable Person any such expenses
promptly upon written request (which request shall include an undertaking by the Indemnifiable Person to repay the amount of such advance
if it shall ultimately be determined as provided below that the Indemnifiable Person is not entitled to be indemnified); provided
that the Company shall have the right, at its own expense, to assume and defend any such action, suit or proceeding, and once the Company
gives notice of its intent to assume the defense, the Company shall have sole control over such defense with counsel of recognized standing
of the Company’s choice. The foregoing right of indemnification shall not be available to an Indemnifiable Person to the extent
that a final judgment or other final adjudication (in either case not subject to further appeal) binding upon such Indemnifiable Person
determines that the acts or omissions or determinations of such Indemnifiable Person giving rise to the indemnification claim resulted
from such Indemnifiable Person’s fraud or willful criminal act or willful criminal omission or that such right of indemnification
is otherwise prohibited by law or by the Company’s certificate of incorporation or bylaws. The foregoing right of indemnification
shall not be exclusive of or otherwise supersede any other rights of indemnification to which such Indemnifiable Persons may be entitled
under the Company’s certificate of incorporation or by-laws, as a matter of law, individual indemnification agreement or contract,
or otherwise, or any other power that the Company may have to indemnify such Indemnifiable Persons or hold them harmless.

 

(f)            Board.
The Board may at any time and from time to time grant Awards and administer the Plan with respect to such Awards. In any such case, the
Board shall have all the authority granted to the Committee under the Plan.

 

5.           Grant
of Awards; Available Shares for Awards; Limitations.

 

(a)           Awards.
The Committee may grant Awards to one or more Eligible Persons. All Awards granted under the Plan shall vest and, if applicable, become
exercisable in such manner and on such date or dates or upon such event or events as determined by the Committee and as set forth in
an Award Agreement.

 

    7

     

    

 

(b)           Available Shares. Subject to Section 11 of the Plan and subsection (e) below, the maximum number of Shares available for
issuance under the Plan shall not exceed 6,333,333, plus the number of Shares set forth in this Section 5(b) (the “Share Pool”)
on a fully diluted basis assuming that all shares available for issuance under the Plan are issued and outstanding. The Share Pool will
automatically increase each fiscal year following the Effective Date beginning with fiscal year 2022 and ending with fiscal year 2026
by the lesser of (i) 1% of the total number of Shares outstanding on the last day of the immediately preceding fiscal year on a fully
diluted basis assuming that all shares available for issuance under the Plan are issued and outstanding or (ii) such number of Shares
determined by the Board. The increase shall occur on the first day of each such fiscal year or another day selected by the Board during
such fiscal year. Without limiting Section 11(a), the Share Pool shall at all times through the occurrence of the Company’s initial
public offering, or the consummation of a merger or other transaction that results in a listing of the Company’s Shares on the
NASDAQ or another securities exchange, be equal to 11.24% of the fully-diluted equity of the Company.

 

(c)           Incentive Stock Options Limit. The maximum number of Shares that may be delivered pursuant to the exercise of Incentive
Stock Options granted under the Plan shall not exceed 3,166,667.

 

(d)           Director
Compensation Limit. The maximum amount (based on the fair value of Shares underlying Awards on the grant date as determined in accordance
with applicable financial accounting rules) of Awards that may be granted in any single fiscal year to any non-employee member of the
Board, taken together with any cash fees paid to such non-employee member of the Board during such fiscal year, shall be $900,000.

 

(e)           Share Counting. The Share Pool shall be reduced by the number of Shares delivered for each Award granted under the Plan
that is valued by reference to a Share; provided that Awards that are valued by reference to Shares but are required to or may
be paid in cash pursuant to their terms shall not reduce the Share Pool. If and to the extent that Awards terminate, expire or are cash
settled, canceled, forfeited, exchanged or surrendered without having been exercised, vested or settled, the Shares subject to such Awards
shall again be available for Awards under the Share Pool. In addition, any (i) Shares tendered by Participants, or withheld by the
Company, as full or partial payment to the Company upon the exercise of Options granted under the Plan; (ii) Shares reserved for
issuance upon the grant of Stock Appreciation Rights, to the extent that the number of reserved Shares exceeds the number of Shares actually
issued upon the exercise of the Stock Appreciation Rights; and (iii) Shares withheld by, or otherwise remitted to, the Company to
satisfy a Participant’s tax withholding obligations upon the exercise of Options or SARs granted under the Plan, or upon the lapse
of restrictions on, or settlement of, an Award, shall again be available for Awards under the Share Pool.

 

(f)            Source
of Shares. Shares delivered by the Company in settlement of Awards may be authorized and unissued Shares, Shares held in the treasury
of the Company, Shares purchased on the open market or by private purchase, or a combination of the foregoing.

 

(g)           Substitute
Awards. Substitute Awards shall not reduce the Shares authorized for grant under the Plan. Additionally, in the event that a company
acquired by the Company or any Affiliate or with which the Company or any Affiliate combines has shares available under a pre-existing
plan approved by stockholders and not approved in contemplation or such acquisition or combination, the shares available for grant pursuant
to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation
ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the
entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for
grant under the Plan; provided that Awards using such available shares shall not be made after the date awards or grants could
have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals
who were not employed by or providing services to the Company immediately prior to such acquisition or combination. Notwithstanding the
foregoing, Substitute Awards issued or intended as “incentive stock options” within the meaning of Section 422 of the
Code shall be counted against the aggregate number of Incentive Stock Options available under the Plan.

 

    8

     

    

 

6.            Eligibility. Participation shall be for Eligible Persons who have been selected by the Committee or its delegate to receive
grants under the Plan (each such Eligible Person, a “Participant”). Holders of options and other types of awards
granted by a company acquired by the Company or with which the Company combines are eligible for grants of Substitute Awards under the
Plan to the extent permitted under applicable regulations of any stock exchange on which the Company is listed.

 

7.           Options.

 

(a)           Generally. Each Option shall be subject to the conditions set forth in the Plan and in the applicable Award Agreement. All
Options granted under the Plan shall be Nonqualified Stock Options unless the Award Agreement expressly states otherwise. Incentive Stock
Options shall be granted only subject to and in compliance with Section 422 of the Code, and only to Eligible Persons who are employees
of the Company and its Affiliates and who are eligible to receive an Incentive Stock Option under the Code. If for any reason an Option
intended to be an Incentive Stock Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then, to the extent
of such nonqualification, such Option or portion thereof shall be regarded as a Nonqualified Stock Option properly granted under the Plan.

 

(b)           Exercise Price. The exercise price per Share for each Option, which is the purchase price per Share underlying the Option,
shall be determined by the Committee at the time of grant and, except in the case of a Substitute Award, such exercise price shall not
be less than 100% of the Fair Market Value of a Share on the date of grant of such Option. Any modification to the exercise price of an
outstanding Option shall be subject to the prohibition on repricing set forth in Section 14(b).

 

(c)           Vesting, Exercise and Expiration. The Committee shall determine the manner and timing of vesting, exercise and expiration
of Options. The period between the date of grant and the scheduled expiration date of the Option (“Option Period”)
shall not exceed 10 years, unless the Option Period (other than in the case of an Incentive Stock Option) would expire at a time when
trading in the Shares is prohibited by the Company’s insider-trading policy or a Company-imposed “blackout period,”
in which case, unless otherwise provided by the Committee, the Option Period may be extended automatically until the 30th day following
the expiration of such prohibition (so long as such extension shall not violate Section 409A of the Code) or the Committee may provide
for the automatic exercise of such Option prior to the expiration of the Option Period. The Committee may accelerate the vesting and/or
exercisability of any Option, which acceleration shall not affect any other terms and conditions of such Option.

 

(d)           Method
of Exercise and Form of Payment. No Shares shall be delivered pursuant to any exercise of an Option until the Participant has
paid the exercise price to the Company in full, and an amount equal to any applicable U.S. federal, state and local income and
employment taxes and non-U.S. income and employment taxes, social contributions and any other tax-related items required to be
withheld. Options may be exercised by delivery of written or electronic notice of exercise to the Company or its designee (including
a third-party administrator) in accordance with the terms of the Option and the Award Agreement, accompanied by payment of the
exercise price and such applicable taxes. The exercise price and delivery of all applicable required withholding taxes shall be
payable (i) in cash or by check or cash equivalent or (ii) by such other method as the Committee may permit, in its sole
discretion, including without limitation: (A) in the form of other property (including previously owned Shares; provided that
such Shares are not subject to any pledge or other security interest) having a Fair Market Value on the date of exercise equal to
the exercise price and all applicable required withholding taxes; (B) if there is a public market for the Shares at such time,
by means of a broker-assisted “cashless exercise” pursuant to which the Company or its designee (including third-party
administrators) is delivered a copy of irrevocable instructions to a stockbroker to sell the Shares otherwise deliverable upon the
exercise of the Option and to deliver promptly to the Company an amount equal to the exercise price and all applicable required
withholding taxes against delivery of the Shares to settle the applicable trade; or (C) by means of a “net
exercise” procedure effected by withholding the minimum number of Shares otherwise deliverable in respect of an Option that
are needed to pay for the exercise price and all applicable required withholding taxes. Notwithstanding the foregoing, unless
otherwise determined by the Committee or as set forth in an Award Agreement, if, on the last day of the Option Period, the Fair
Market Value of a Share exceeds the exercise price, the Participant has not exercised the Option and the Option has not previously
expired, such Option shall be deemed exercised by the Participant on such last day by means of a “net exercise”
procedure described above. In all events of cashless or net exercise, any fractional Shares shall be settled in cash.

 

    9

     

    

 

(e)           Notification
upon Disqualifying Disposition of an Incentive Stock Option. Each Participant awarded an Incentive Stock Option under the Plan shall
notify the Company in writing immediately after the date on which the Participant makes a disqualifying disposition of any Share acquired
pursuant to the exercise of such Incentive Stock Option. A disqualifying disposition is any disposition (including, without limitation,
any sale) of such Share before the later of (i) two years after the date of grant of the Incentive Stock Option and (ii) one
year after the date of exercise of the Incentive Stock Option. The Company may, if determined by the Committee and in accordance with
procedures established by the Committee, retain possession, as agent for the applicable Participant, of any Share acquired pursuant to
the exercise of an Incentive Stock Option until the end of the period described in the preceding sentence, subject to complying with
any instruction from such Participant as to the sale of such Share.

 

(f)            Compliance with Laws. Notwithstanding the foregoing, in no event shall the Participant be permitted to exercise an Option
in a manner that the Committee determines would violate the Sarbanes-Oxley Act of 2002, or any other applicable law or the applicable
rules and regulations of the Securities and Exchange Commission or the applicable rules and regulations of any securities exchange or
inter-dealer quotation service on which the Shares of the Company are listed or quoted.

 

(g)           Incentive Stock Option Grants to 10% Stockholders. Notwithstanding anything to the contrary in this Section 7, if an
Incentive Stock Option is granted to a Participant who owns stock representing more than 10 percent of the voting power of all classes
of stock of the Company or of a parent or subsidiary of the Company (within the meaning of Sections 424(e) and 424(f) of the Code),
the Option Period shall not exceed five years from the date of grant of such Option and the exercise price shall be at least 110% of the
Fair Market Value (on the date of grant) of the shares subject to the Option.

 

(h)           $100,000
Per Year Limitation for Incentive Stock Options. To the extent that the aggregate Fair Market Value (determined as of the date of
grant) of Shares for which Incentive Stock Options are exercisable for the first time by any Participant during any calendar year (under
all plans of the Company) exceeds $100,000, such excess Incentive Stock Options shall be treated as Nonqualified Stock Options.

 

8.           Stock
Appreciation Rights (SARs).

 

(a)           Generally.
Each SAR shall be subject to the conditions set forth in the Plan and in the applicable Award Agreement.

 

(b)           Exercise
Price. The exercise or hurdle price per Share for each SAR shall be determined by the Committee at the time of grant and, except
in the case of a Substitute Award, such exercise or hurdle price shall not be less than 100% of the Fair Market Value of a Share on the
date of grant of such SAR. Any modification to the exercise or hurdle price of an outstanding SAR shall be subject to the prohibition
on repricing set forth in Section 14(b).

 

    10

     

    

 

(c)           Vesting,
Exercise and Expiration. The Committee shall determine the manner and timing of vesting, exercise and expiration of SARs. The period
between the date of grant and the scheduled expiration of the SAR (the “SAR Period”) shall not exceed 10 years,
unless the SAR Period would expire at a time when trading in the Shares is prohibited by the Company’s insider-trading policy or
a Company-imposed “blackout period,” in which case, unless otherwise provided by the Committee, the SAR Period may be extended
automatically until the 30th day following the expiration of such prohibition (so long as such extension shall not violate Section 409A
of the Code) or the Committee may provide for the automatic exercise of such SAR prior to the expiration of the SAR Period. The Committee
may accelerate the vesting and/or exercisability of any SAR, which acceleration shall not affect any other terms and conditions of such
SAR.

 

(d)           Method
of Exercise and Form of Payment. SARs may be exercised by delivery of written or electronic notice of exercise to the Company or
its designee (including a third-party administrator) in accordance with the terms of the SAR and the Award Agreement, specifying the
number of SARs to be exercised and the date on which such SARs were awarded. Upon the exercise of a SAR, the Company shall pay to the
holder thereof an amount equal to the number of Shares subject to the SAR that are being exercised multiplied by the excess, if any,
of the Fair Market Value of one Share on the exercise date over the exercise price, less an amount equal to any applicable U.S. federal,
state and local income and employment taxes and non-U.S. income and employment taxes, social contributions and any other tax-related
items required to be withheld. The Company shall pay such amount in cash, in Shares valued at Fair Market Value as determined on the
date of exercise, or any combination thereof, as determined by the Committee. Any fractional Shares shall be settled in cash. Notwithstanding
the foregoing, unless otherwise determined by the Committee or as set forth in the Award Agreement, if, on the last day of the SAR Period,
the Fair Market Value exceeds the exercise price, the Participant has not exercised the SAR and the SAR has previously expired, such
SAR shall be deemed to have been exercised by the Participant on such last day and the Company shall make the appropriate payment therefor.

 

9.           Restricted
Stock and Restricted Stock Units.

 

(a)           Generally.
Each Restricted Stock and Restricted Stock Unit shall be subject to the conditions set forth in the Plan and the applicable Award Agreement.
The Committee shall establish restrictions applicable to Restricted Stock and Restricted Stock Units, including the period over which
the restrictions shall apply (the “Restricted Period”), and the time or times at which Restricted Stock or
Restricted Stock Units shall become vested. The Committee may accelerate the vesting and/or the lapse of any or all of the restrictions
on Restricted Stock and Restricted Stock Units, which acceleration shall not affect any other terms and conditions of such Awards. No
Share shall be issued at the time an Award of Restricted Stock Units is made, and the Company will not be required to set aside a fund
for the payment of any such Award.

 

(b)           Director
Retainer Fees. To the extent permitted by the Board and subject to such rules, approvals and conditions as the Committee may impose
from time to time, an Eligible Person who is a non-employee Director may elect to receive all or a portion of such Eligible Person’s
cash director fees and other cash director compensation payable for director services provided to the Company by such Eligible Person
in any fiscal year, in whole or in part, in the form of Restricted Stock Units or Shares, which shall not count against the Share Pool.

 

    11

     

    

 

(c)           Stock
Certificates; Escrow or Similar Arrangement. Upon the grant of Restricted Stock, the Committee shall cause Share(s) to be registered
in the name of the Participant, which may be evidenced in any manner the Committee may deem appropriate, including in book-entry form
subject to the Company’s directions or the issuance of a stock certificate registered in the name of the Participant. In such event,
the Committee may provide that such certificates shall be held by the Company or in escrow rather than delivered to the Participant pending
vesting and release of restrictions, in which case the Committee may require the Participant to execute and deliver to the Company or
its designee (including third-party administrators) (i) an escrow agreement satisfactory to the Committee, if applicable, and (ii) the
appropriate stock power (endorsed in blank) with respect to the Restricted Stock.

 

(e)           Voting
and Rights as a Stockholder. Subject to the restrictions set forth in the applicable Award Agreement, a Participant generally shall
have the rights and privileges of a stockholder with respect to Awards of Restricted Stock, including, without limitation, the right
to vote such Shares of Restricted Stock and the right to receive dividends. Unless otherwise provided by the Committee or in an Award
Agreement, a Restricted Stock Unit shall not convey to the Participant the rights and privileges of a stockholder with respect to the
Share subject to the Restricted Stock Unit, such as the right to vote or the right to receive dividends, unless and until a Share is
issued to the Participant to settle the Restricted Stock Unit.

 

(f)            Restrictions; Forfeiture. Restricted Stock and Restricted Stock Units awarded to the Participant shall be subject to forfeiture
until the expiration of the Restricted Period and the attainment of any other vesting criteria established by the Committee, and shall
be subject to the restrictions on transferability set forth in the Award Agreement. Unless otherwise provided by the Committee, in the
event of any forfeiture, all rights of the Participant to such Restricted Stock (or as a stockholder with respect thereto) and to such
Restricted Stock Units, as applicable, shall terminate without further action or obligation on the part of the Company. The Committee
shall have the authority to remove any or all of the restrictions on the Restricted Stock and Restricted Stock Units whenever it may determine
that, by reason of changes in applicable laws or other changes in circumstances arising after the date of grant of the Restricted Stock
Award or Restricted Stock Unit Award, such action is appropriate.

 

(g)          Delivery
of Restricted Stock and Settlement of Restricted Stock Units.

 

(i)                Upon
the expiration of the Restricted Period with respect to any Shares of Restricted Stock and the attainment of any other vesting criteria,
the restrictions set forth in the applicable Award Agreement shall be of no further force or effect, except as set forth in the Award
Agreement. If an escrow arrangement is used, upon such expiration the Company shall deliver to the Participant or such Participant’s
beneficiary or Permitted Transferee (via book-entry notation or, if applicable, in stock certificate form) the Shares of Restricted Stock
with respect to which the Restricted Period has expired (rounded down to the nearest full Share). To the extent provided in an Award
Agreement, dividends, if any, that may have been withheld by the Company and attributable to the Restricted Stock shall be distributed
to the Participant in cash or in Shares (or a combination of cash and Shares) having a Fair Market Value (on the date of distribution)
equal to the amount of such dividends, upon the release of restrictions on the Restricted Stock.

 

(ii)               Unless
otherwise provided by the Committee in an Award Agreement, upon the expiration of the Restricted Period and the attainment of any other
vesting criteria established by the Committee in the applicable Award Agreement, with respect to any outstanding Restricted Stock Units,
the Company shall deliver to the Participant, or such Participant’s beneficiary (via book-entry notation or, if applicable, in
stock certificate form), one Share (or other securities or other property, as applicable) for each such outstanding Restricted Stock
Unit that has not then been forfeited and with respect to which the Restricted Period has expired and any other such vesting criteria
are attained (“Released Unit”); provided, however, that the Committee may elect to (A) pay
cash or part cash and part Shares in lieu of delivering only Shares in respect of such Released Units or (B) defer the delivery
of Shares (or cash or part Shares and part cash, as the case may be) beyond the expiration of the Restricted Period if such extension
would not cause adverse tax consequences under Section 409A of the Code. If a cash payment is made in lieu of delivering Shares,
the amount of such payment shall be equal to the Fair Market Value of the Shares as of the date on which the Shares would have otherwise
been delivered to the Participant in respect of such Restricted Stock Units. To the extent provided in an Award Agreement, dividend equivalents,
if any, that may have been withheld by the Company and attributable to the Restricted Stock Units shall be distributed to the Participant
in cash or in Shares (or a combination of cash and Shares) having a Fair Market Value (on the date of distribution) equal to the amount
of such dividends, upon the release of restrictions on the Restricted Stock Units.

 

    12

     

    

 

(h)          
Legends on Restricted Stock. Each certificate representing Shares of Restricted Stock awarded under the Plan, if any, shall
bear as appropriate a legend substantially in the form of the following in addition to any other information the Company deems appropriate
until the lapse of all restrictions with respect to such Shares:

 

TRANSFER OF THIS CERTIFICATE AND THE SHARES
REPRESENTED HEREBY IS RESTRICTED PURSUANT TO THE TERMS OF THE TERAWULF 2021 OMNIBUS INCENTIVE
PLAN AND A RESTRICTED STOCK AWARD AGREEMENT, DATED AS OF __________, BETWEEN TERAWULF INC. AND
_________. A COPY OF SUCH PLAN AND AWARD AGREEMENT IS ON FILE AT THE PRINCIPAL EXECUTIVE OFFICE OF TERAWULF
INC. 

 

10.        
Other Stock-Based Awards and Other Cash-Based Awards. The Committee may issue unrestricted Shares, rights to receive future
grants of Awards, or other Awards denominated in Shares (including performance shares or performance units), or Awards that provide for
cash payments based in whole or in part on the value or future value of Shares (“Other Stock-Based Awards”)
and Other Cash-Based Awards under the Plan to Eligible Persons, alone or in tandem with other Awards, in such amounts as the Committee
shall from time to time determine. Each Other Stock-Based Award shall be evidenced by an Award Agreement, which may include conditions
including, without limitation, the payment by the Participant of the Fair Market Value of such Shares on the date of grant. Each Other
Cash-Based Award granted under the Plan shall be evidenced in such form as the Committee may determine from time to time.

 

11.        
Changes in Capital Structure and Similar Events. In the event of (a) any dividend (other than regular cash
dividends) or other distribution (whether in the form of cash, Shares, other securities or other property), recapitalization (including
a subsequent investment), stock split, reverse stock split, reorganization, merger, amalgamation, consolidation, split-up, split-off,
spin-off, combination, repurchase or exchange of Shares or other securities of the Company, issuance of warrants or other rights to acquire
Shares or other securities of the Company, or other similar corporate transaction or event (including, without limitation, a Change in
Control) that affects the Shares or (b) unusual or nonrecurring events (including, without limitation, a Change
in Control) affecting the Company, any Affiliate, or the financial statements of the Company or any Affiliate, or changes in applicable
rules, rulings, regulations or other requirements of any governmental body or securities exchange or inter-dealer quotation service,
accounting principles or law, such that in any case an adjustment is determined by the Committee to be necessary or appropriate, then
the Committee shall (other than with respect to Other Cash-Based Awards), to the extent permitted under Section 409A of the Code,
make any such adjustments in such manner as it may deem equitable, including, without limitation, any or all of the following:

 

(i)                adjusting
any or all of (A) the number of Shares or other securities of the Company (or number and kind of other securities or other
property) that may be delivered in respect of Awards or with respect to which Awards may be granted under the Plan (including,
without limitation, adjusting any or all of the limitations under Section 5 of the Plan) and (B) the terms of any
outstanding Award, including, without limitation, (1) the number of Shares or other securities of the Company (or number and
kind of other securities or other property) subject to outstanding Awards or to which outstanding Awards relate, (2) the
exercise price with respect to any Award and/or (3) any applicable performance measures;

 

    13

     

    

 

(ii)              
providing for a substitution or assumption of Awards (or awards of an acquired company), accelerating the delivery, vesting and/or
exercisability of, lapse of restrictions and/or other conditions on, or termination of, Awards or providing for a period of time (which
shall not be required to be more than ten (10) days) for Participants to exercise outstanding Awards prior to the occurrence of such event
(and any such Award not so exercised shall terminate or become no longer exercisable upon the occurrence of such event); and

 

(iii)             
cancelling any one or more outstanding Awards (or awards of an acquired company) and causing to be paid to the holders thereof,
in cash, Shares, other securities or other property, or any combination thereof, the value of such Awards, if any, as determined by the
Committee (which, if applicable, may be based upon the price per Share received or to be received by other stockholders of the Company
in such event), including, without limitation, in the case of an outstanding Option or SAR, a cash payment in an amount equal to the
excess, if any, of the Fair Market Value (as of a date specified by the Committee) of the Shares subject to such Option or SAR over the
aggregate exercise price of such Option or SAR, respectively (it being understood that, in such event, any Option or SAR having a per
Share exercise price equal to, or in excess of, the Fair Market Value (as of the date specified by the Committee) of a Share subject
thereto may be canceled and terminated without any payment or consideration therefor);

 

provided, however, that the Committee
shall make an equitable or proportionate adjustment to outstanding Awards to reflect any “equity restructuring” (within the
meaning of the Financial Accounting Standards Codification Topic 718 (or any successor pronouncement thereto)). Except as otherwise determined
by the Committee, any adjustment in Incentive Stock Options under this Section 11 (other than any cancellation of Incentive Stock
Options) shall be made only to the extent not constituting a “modification” within the meaning of Section 424(h)(3)
of the Code, and any adjustments under this Section 11 shall be made in a manner that does not adversely affect the exemption provided
pursuant to Rule 16b-3 promulgated under the Exchange Act. Any such adjustment hereunder, upon notice, shall be conclusive and binding
for all purposes. In anticipation of the occurrence of any event listed in the first sentence of this Section 11, for reasons of
administrative convenience, the Committee in its sole discretion may refuse to permit the exercise of any Award or as it otherwise may
determine during a period of up to 30 days prior to, and/or up to 30 days after, the anticipated occurrence of any such event.

 

12.         
Effect of Termination of Service or a Change in Control on Awards.

 

(a)           
Termination. To the extent permitted under Section 409A of the Code, the Committee may provide, by rule or regulation
or in any applicable Award Agreement, or may determine in any individual case, the circumstances in which, and to the extent to which,
an Award may be exercised, settled, vested, paid or forfeited in the event of the Participant’s termination of service with the
Company or an Affiliate prior to the end of a performance period or vesting, exercise or settlement of such Award.

 

(b)          
Change in Control(c). Except to the extent otherwise provided in an Award Agreement, or any applicable employment, consulting,
change-in-control, severance or other agreement between the Participant and the Company or an Affiliate, in the event of a Change in Control,
notwithstanding any provision of the Plan to the contrary:

 

    14

     

    

 

(i)               
 If the acquirer or successor company in such Change in Control has agreed to provide for the substitution, assumption, exchange
or other continuation of Awards granted pursuant to the Plan, then, if the Participant’s employment with or service to the Company
or an Affiliate is terminated (x) by the Company or Affiliate without Cause (and other than due to death or Disability) or (y) by the
Participant for Good Reason, in each case, on or within 12 months following a Change in Control, then unless otherwise provided by the
Committee, all Options and SARs held by such Participant shall become immediately exercisable with respect to 100% of the shares subject
to such Options and SARs, and that the Restricted Period (and any other conditions) shall expire immediately with respect to 100% of the
shares of Restricted Stock and Restricted Stock Units and any other Awards (other than an Other Cash-Based Award) held by such Participant.

 

(ii)              
If the acquirer or successor company in such Change in Control has not agreed to provide for the substitution, assumption, exchange
or other continuation of Awards granted pursuant to the Plan, then unless otherwise provided by the Committee, all Options and SARs held
by such Participant shall become immediately exercisable with respect to 100% of the shares subject to such Options and SARs, and the
Restricted Period (and any other conditions) shall expire immediately with respect to 100% of the shares of Restricted Stock and Restricted
Stock Units and any other Awards (other than an Other Cash-Based Award) held by such Participant.

 

(iii)              In
addition, the Committee may upon at least ten (10) days’ advance notice to the affected Participants, cancel any outstanding
Award and pay to the holders thereof, in cash, securities or other property (including of the acquiring or successor company), or
any combination thereof, the value of such Awards based upon the price per Share received or to be received by other stockholders of
the Company in the event (it being understood that any Option or SAR having a per-share exercise or hurdle price equal to, or in
excess of, the Fair Market Value (as of the date specified by the Committee) of a Share subject thereto may be canceled and
terminated without any payment or consideration therefor). Notwithstanding the above, the Committee shall exercise such discretion
over the timing of settlement of any Award subject to Code Section 409A at the time such Award is granted.

 

To the extent
practicable, the provisions of this Section 12(b) shall occur in a manner and at a time that allows affected Participants the
ability to participate in the Change in Control transaction with respect to the Shares subject to their Awards.

 

13.          Deferred
Awards. The Committee is authorized, subject to limitations under applicable law, to grant to Participants Deferred Awards,
which may be a right to receive Shares or cash under the Plan (either independently or as an element of or supplement to any other
Award under the Plan), including, as may be required by any applicable law or regulations or determined by the Committee, in lieu of
any annual bonus, commission or retainer that may be payable to a Participant under any applicable, bonus, commission or retainer
plan or arrangement. The Committee shall determine the terms and conditions of such Deferred Awards, including, without limitation,
the method of converting the amount of annual bonus into a Deferred Award, if applicable, and the form, vesting, settlement,
forfeiture and cancellation provisions or any other criteria, if any, applicable to such Deferred Awards. Shares underlying a
Share-denominated Deferred Award, which is subject to a vesting schedule or other conditions or criteria, including forfeiture or
cancellation provisions, set by the Committee shall not be issued until or following the date that those conditions and criteria
have been satisfied. Deferred Awards shall be subject to such restrictions as the Committee may impose (including any limitation on
the right to vote a Share underlying a Deferred Award or the right to receive any dividend, dividend equivalent or other right),
which restrictions may lapse separately or in combination at such time or times, in such installments or otherwise, as the Committee
may deem appropriate. The Committee may determine the form or forms (including cash, Shares, other Awards, other property or any
combination thereof) in which payment of the amount owing upon settlement of any Deferred Award may be made.

 

    15

     

    

 

14.         
Amendments and Termination.

 

(a)           
Amendment and Termination of the Plan. The Board may amend, alter, suspend, discontinue or terminate the Plan or any portion
thereof at any time; provided that no such amendment, alteration, suspension, discontinuance or termination shall be made without
stockholder approval if such approval is necessary to comply with any tax or regulatory requirement applicable to the Plan (including,
without limitation, as necessary to comply with any applicable rules or requirements of any securities exchange or inter-dealer quotation
service on which the Shares may be listed or quoted, for changes in GAAP to new accounting standards); provided, further,
that any such amendment, alteration, suspension, discontinuance or termination that would materially and adversely affect the rights of
any Participant or any holder or beneficiary of any Award theretofore granted shall not to that extent be effective without the consent
of the affected Participant, holder or beneficiary, unless the Committee determines that such amendment, alteration, suspension, discontinuance
or termination is either required or advisable in order for the Company, the Plan or the Award to satisfy any applicable law or regulation.
No Awards may be granted or awarded during any period of suspension, after termination of the Plan or after the Expiration Date.

 

(b)          
Amendment of Award Agreements. The Committee may, to the extent not inconsistent with the terms of any applicable Award
Agreement or the Plan, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate,
any Award theretofore granted or the associated Award Agreement, prospectively or retroactively (including after the Participant’s
termination of employment or service with the Company); provided that any such waiver, amendment, alteration, suspension, discontinuance,
cancellation or termination that would materially and adversely affect the rights of any Participant with respect to any Award theretofore
granted shall not to that extent be effective without the consent of the affected Participant unless the Committee determines that such
waiver, amendment, alteration, suspension, discontinuance, cancellation or termination is either required or advisable in order for the
Company, the Plan or the Award to satisfy any applicable law or regulation; provided, further, that except as otherwise
permitted under Section 11 of the Plan, if (i) the Committee reduces the exercise price of any Option or of any SAR, (ii) the
Committee cancels any outstanding Option or SAR and replaces it with a new Option or SAR (with a lower exercise price, as the case may
be) or other Award or cash in a manner that would either (A) be reportable on the Company’s proxy statement or Form 10-K (if
applicable) as Options that have been “repriced” (as such term is used in Item 402 of Regulation S-K promulgated under the
Exchange Act) or (B) result in any “repricing” for financial statement reporting purposes (or otherwise cause the Award
to fail to qualify for equity accounting treatment), (iii) take any other action that is considered a “repricing” for
purposes of the stockholder approval rules of the applicable securities exchange or inter-dealer quotation service on which the Share
is listed or quoted and/or (iv) cancel any outstanding Option or SAR that has a per Share exercise price (as applicable) at or above
the Fair Market Value of a Share on the date of cancellation, and pay any consideration to the holder thereof, whether in cash, securities
or other property, or any combination thereof, then, in the case of the immediately preceding clauses (i) through (iv), any such action
shall not be effective without stockholder approval.

 

15.             
General.

 

(a)           Award
Agreements; Other Agreements. Each Award (other than an Other Cash-Based Award) under the Plan shall be evidenced by an Award
Agreement, which shall be delivered (whether in written or electronic form) to the Participant and shall specify the terms and
conditions of the Award and any rules applicable thereto. In the event of any conflict between the terms of the Plan and any Award
Agreement or employment, change-in-control, severance or other agreement in effect with the Participant, the terms of the Plan shall
control.

 

    16

     

    

 

(b)          
Nontransferability.

 

(i)                
Each Award shall be exercisable only by the Participant during the Participant’s lifetime or, if permissible under applicable
law or the Plan, by the Participant’s legal guardian or representative or beneficiary or Permitted Transferee. No Award may be assigned,
alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent
and distribution or as set forth below in clause (ii), and any such purported assignment, alienation, pledge, attachment, sale, transfer
or encumbrance shall be void and unenforceable against the Company or an Affiliate; provided that the designation of a beneficiary
shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.

 

(ii)              
Notwithstanding the foregoing, the Committee may permit Awards (other than Incentive Stock Options) to be transferred by the Participant,
without consideration, subject to such rules as the Committee may adopt, to (A) any person who is a “family member” of
the Participant, as such term is used in the instructions to Form S-8 under the Securities Act or any successor form of registration statements
promulgated by the Securities and Exchange Commission (collectively, the “Immediate Family Members”); (B) a
trust solely for the benefit of the Participant or the Participant’s Immediate Family Members; (C) a partnership or limited
liability company whose only partners or stockholders are the Participant and the Participant’s Immediate Family Members; or (D) any
other transferee as may be approved either (1) by the Board or the Committee or (2) as provided in the applicable Award Agreement
(each transferee described in clause (A), (B), (C) or (D) above is hereinafter referred to as a “Permitted Transferee”);
provided that the Participant gives the Committee or its delegate advance written notice describing the terms and conditions of the proposed
transfer and the Committee or its delegate notifies the Participant in writing that such a transfer would comply with the requirements
of the Plan.

 

(iii)             
The terms of any Award transferred in accordance with the immediately preceding subsection shall apply to the Permitted Transferee,
and any reference in the Plan, or in any applicable Award Agreement, to the Participant shall be deemed to refer to the Permitted Transferee,
except that, unless otherwise provided by the Committee: (A) Permitted Transferees shall not be entitled to transfer any Award, other
than by will or the laws of descent and distribution; (B) Permitted Transferees shall not be entitled to exercise any transferred
Option unless there shall be in effect a registration statement on an appropriate form covering the Shares to be acquired pursuant to
the exercise of such Option if the Committee determines, consistent with any applicable Award Agreement, that such a registration statement
is necessary or appropriate; (C) the Committee or the Company shall not be required to provide any notice to a Permitted Transferee,
whether or not such notice is or would otherwise have been required to be given to the Participant under the Plan or otherwise; (D) the
consequences of the termination of the Participant’s employment by, or services to, the Company or an Affiliate under the terms
of the Plan and the applicable Award Agreement shall continue to be applied with respect to the transferred Award, including, without
limitation, that an Option shall be exercisable by the Permitted Transferee only to the extent, and for the periods, specified in the
Plan and the applicable Award Agreement; and (E) any non-competition, non-solicitation, non-disparagement, non-disclosure of confidential
information or other restrictive covenants contained in any Award Agreement or other agreement between the Participant and the Company
or any Affiliate shall continue to apply to the Participant.

 

(c)            Dividends
and Dividend Equivalents. The Committee may specify in the applicable Award Agreement that any or all dividends, dividend
equivalents or other distributions, as applicable, paid on Awards of Restricted Stock or Restricted Stock Units prior to vesting or
settlement, as applicable, be paid either in cash or in additional Shares and either on a current or deferred basis and that such
dividends, dividend equivalents or other distributions may be reinvested in additional Shares, which may be subject to the same
restrictions as the underlying Awards.

 

    17

     

    

 

(d)          
No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to the Plan or an Award, and the Committee
shall determine whether cash or other securities shall be paid or transferred in lieu of any fractional Shares, or whether such fractional
Shares or any rights thereto shall be cancelled, terminated or otherwise eliminated.

 

(e)           
Tax Withholding.

 

(i)               
The Participant shall be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right
(but not the obligation) and is hereby authorized to withhold, from any cash, Shares, other securities or other property deliverable under
any Award or from any compensation or other amounts owing to the Participant, the amount (in cash, Shares, other securities or other property)
of any required withholding taxes (up to the maximum permissible withholding amounts) in respect of an Award, its exercise, or any payment
or transfer under an Award or under the Plan and to take such other action that the Committee or the Company deems necessary to satisfy
all obligations for the payment of such withholding taxes.

 

(ii)              
Without limiting the generality of paragraph (i) above, the Committee may permit the Participant to satisfy, in whole or in part,
the foregoing withholding liability by (A) payment in cash, (B) the delivery of Shares (which Shares are not subject to any
pledge or other security interest) owned by the Participant having a Fair Market Value on such date equal to such withholding liability
or (C) having the Company withhold from the number of Shares otherwise issuable or deliverable pursuant to the exercise or settlement
of the Award a number of Shares with a Fair Market Value on such date equal to such withholding liability. In addition, subject to any
requirements of applicable law, the Participant may also satisfy the tax withholding obligations by other methods, including selling Shares
that would otherwise be available for delivery; provided that the Board or the Committee has specifically approved such payment
method in advance.

 

(f)           
No Claim to Awards; No Rights to Continued Employment, Directorship or Engagement. No employee, Director of the Company,
consultant providing service to the Company or an Affiliate, or other person shall have any claim or right to be granted an Award under
the Plan or, having been selected for the grant of an Award, to be selected for a grant of any other Award. There is no obligation for
uniformity of treatment of Participants or holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee’s
determinations and interpretations with respect thereto need not be the same with respect to each Participant and may be made selectively
among Participants, whether or not such Participants are similarly situated. Neither the Plan nor any action taken hereunder shall be
construed as giving any Participant any right to be retained in the employ or service of the Company or an Affiliate, or to continue in
the employ or the service of the Company or an Affiliate, nor shall it be construed as giving any Participant who is a Director any rights
to continued service on the Board.

 

(g)           International
Participants. With respect to Participants who reside or work outside of the United States or are subject to non-U.S. legal
restrictions or regulations, the Committee may amend the terms of the Plan or appendices thereto, or outstanding Awards, with
respect to such Participants, in order to conform such terms with or accommodate the requirements of local laws, procedures or
practices or to obtain more favorable tax or other treatment for the Participant, the Company or its Affiliates. Without limiting
the generality of this subsection, the Committee is specifically authorized to adopt rules, procedures and sub-plans with provisions
that limit or modify rights on death, disability, retirement or other terminations of employment, available methods of exercise or
settlement of an Award, payment of income, social insurance contributions or payroll taxes, withholding procedures and handling of
any stock certificates or other indicia of ownership that vary with local requirements. The Committee may also adopt rules,
procedures or sub-plans applicable to particular Affiliates or locations.

 

    18

     

    

 

(h)          
Beneficiary Designation. The Participant’s beneficiary shall be the Participant’s spouse (or domestic partner
if such status is recognized by the Company and in such jurisdiction) or, if the Participant is otherwise unmarried at the time of death,
the Participant’s estate, except to the extent that a different beneficiary is designated in accordance with procedures that may
be established by the Committee from time to time for such purpose. Notwithstanding the foregoing, in the absence of a beneficiary validly
designated under such Committee-established procedures and/or applicable law who is living (or in existence) at the time of death of a
Participant residing or working outside the United States, any required distribution under the Plan shall be made to the executor or administrator
of the estate of the Participant, or to such other individual as may be prescribed by applicable law.

 

(i)            
Termination of Employment or Service. The Committee, in its sole discretion, shall determine the effect of all matters and
questions related to the termination of employment of or service of a Participant. Unless determined otherwise by the Committee: (i) neither
a temporary absence from employment or service due to illness, vacation or leave of absence (including, without limitation, a call to
active duty for military service through a Reserve or National Guard unit) nor a transfer from employment or service with the Company
to employment or service with an Affiliate (or vice versa) shall be considered a termination of employment or service with the Company
or an Affiliate; and (ii) if the Participant’s employment with the Company or its Affiliates terminates, but such Participant
continues to provide services with such Company or such Affiliate in a non-employee capacity (including as a non-employee Director) (or
vice versa), such change in status shall not be considered a termination of employment or service with the Company or an Affiliate for
purposes of the Plan.

 

(j)            
No Rights as a Stockholder. Except as otherwise specifically provided in the Plan or any Award Agreement, no person shall
be entitled to the privileges of ownership in respect of Shares that are subject to Awards hereunder until such Shares have been issued
or delivered to that person.

 

(k)           
Government and Other Regulations.

 

(i)               
Nothing in the Plan shall be deemed to authorize the Committee or Board or any members thereof to take any action contrary to applicable
law or regulation, or rules of the NASDAQ or any other securities exchange or inter-dealer quotation service on which the Shares are listed
or quoted.

 

    19

     

    

 

(ii)               The
obligation of the Company to settle Awards in Shares or other consideration shall be subject to all applicable laws, rules and
regulations, and to such approvals by governmental agencies as may be required. Notwithstanding any terms or conditions of any Award
to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be prohibited from offering to sell
or selling, any Shares pursuant to an Award unless such Shares have been properly registered for sale pursuant to the Securities Act
with the Securities and Exchange Commission or unless the Company has received an opinion of counsel, satisfactory to the Company,
that such Shares may be offered for sale or sold without such registration pursuant to and in compliance with the terms of an
available exemption. The Company shall be under no obligation to register for sale under the Securities Act any of the Shares to be
offered for sale or sold under the Plan. The Committee shall have the authority to provide that all Shares or other securities of
the Company or any Affiliate delivered under the Plan shall be subject to such stop-transfer orders and other restrictions as the
Committee may deem advisable under the Plan, the applicable Award Agreement, U.S. federal securities laws, or the rules, regulations
and other requirements of the U.S. Securities and Exchange Commission, any securities exchange or inter-dealer quotation service
upon which such Shares or other securities of the Company are then listed or quoted and any other applicable federal, state, local
or non-U.S. laws, rules, regulations and other requirements, and, without limiting the generality of Section 9 of the Plan, the
Committee may cause a legend or legends to be put on any such certificates of Shares or other securities of the Company or any
Affiliate delivered under the Plan to make appropriate reference to such restrictions or may cause such Shares or other securities
of the Company or any Affiliate delivered under the Plan in book-entry form to be held subject to the Company’s instructions
or subject to appropriate stop-transfer orders. Notwithstanding any provision in the Plan to the contrary, the Committee reserves
the right to add any additional terms or provisions to any Award granted under the Plan that it in its sole discretion deems
necessary or advisable in order that such Award complies with the legal requirements of any governmental entity to whose
jurisdiction the Award is subject.

 

(iii)             
The Committee may cancel an Award or any portion thereof if it determines that legal or contractual restrictions and/or blockage
and/or other market considerations would make the Company’s acquisition of Shares from the public markets, the Company’s issuance
of Shares to the Participant, the Participant’s acquisition of Shares from the Company and/or the Participant’s sale of Shares
to the public markets illegal, impracticable or inadvisable. If the Committee determines to cancel all or any portion of an Award in accordance
with the foregoing, unless prevented by applicable laws, the Company shall pay to the Participant an amount equal to the excess of (A) the
aggregate Fair Market Value of the Shares subject to such Award or portion thereof canceled (determined as of the applicable exercise
date, or the date that the Shares would have been vested or delivered, as applicable), over (B) the aggregate exercise price (in
the case of an Option or SAR) or any amount payable as a condition of delivery of Shares (in the case of any other Award). Such amount
shall be delivered to the Participant as soon as practicable following the cancellation of such Award or portion thereof.

 

(l)           
Payments to Persons Other Than Participants. If the Committee shall find that any person to whom any amount is payable under
the Plan is unable to care for such person’s affairs because of illness or accident, or is a minor, or has died, then any payment
due to such person or such person’s estate (unless a prior claim therefor has been made by a duly appointed legal representative
or a beneficiary designation form has been filed with the Company) may, if the Committee so directs the Company, be paid to such person’s
spouse, child or relative, or an institution maintaining or having custody of such person, or any other person deemed by the Committee
to be a proper recipient on behalf of such person otherwise entitled to payment. Any such payment shall be a complete discharge of the
liability of the Committee and the Company therefor.

 

(m)          
Nonexclusivity of the Plan. Neither the adoption of the Plan by the Board nor the submission of the Plan to the stockholders
of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements
as it may deem desirable, including, without limitation, the granting of stock options or awards otherwise than under the Plan, and such
arrangements may be either applicable generally or only in specific cases.

 

    20

     

    

 

(n)           No
Trust or Fund Created. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any
kind or a fiduciary relationship between the Company or any Affiliate, on the one hand, and the Participant or other person or
entity, on the other hand. No provision of the Plan or any Award shall require the Company, for the purpose of satisfying any
obligations under the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or to
otherwise segregate any assets, nor shall the Company maintain separate bank accounts, books, records or other evidence of the
existence of a segregated or separately maintained or administered fund for such purposes. Participants shall have no rights under
the Plan other than as unsecured general creditors of the Company.

 

(o)          
Reliance on Reports. Each member of the Committee and each member of the Board (and each such member’s respective
designees) shall be fully justified in acting or failing to act, as the case may be, and shall not be liable for having so acted or failed
to act in good faith, in reliance upon any report made by the independent, registered public accounting firm of the Company and its Affiliates
and/or any other information furnished in connection with the Plan by any agent of the Company or the Committee or the Board, other than
such member or designee.

 

(p)          
Relationship to Other Benefits. No payment under the Plan shall be taken into account in determining any benefits under
any pension, retirement, profit-sharing, group insurance or other benefit plan of the Company except as otherwise specifically provided
in such other plan.

 

(q)          
Governing Law. The Plan shall be governed by and construed in accordance with the laws of the State of Delaware, without
regard to principles of conflicts of laws thereof, or principles of conflicts of laws of any other jurisdiction that could cause the application
of the laws of any jurisdiction other than the State of Delaware.

 

(r)           
Severability. If any provision of the Plan or any Award or Award Agreement is or becomes or is deemed to be invalid, illegal
or unenforceable in any jurisdiction or as to any person or entity or Award, or would disqualify the Plan or any Award under any law deemed
applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or, if it cannot be
construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such
provision shall be construed or deemed stricken as to such jurisdiction, person or entity or Award, and the remainder of the Plan and
any such Award shall remain in full force and effect.

 

(s)          
Obligations Binding on Successors. The obligations of the Company under the Plan shall be binding upon any successor corporation
or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or
organization succeeding to all or substantially all of the assets and business of the Company.

 

(t)           
Section 409A of the Code.

 

(i)               
It is intended that the Plan comply with Section 409A of the Code, and all provisions of the Plan shall be construed and interpreted
in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A of the Code. Each Participant is
solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or in respect of such Participant
in connection with the Plan or any other plan maintained by the Company, including any taxes and penalties under Section 409A of
the Code, and neither the Company nor any Affiliate shall have any obligation to indemnify or otherwise hold such Participant or any beneficiary
harmless from any or all of such taxes or penalties. With respect to any Award that is considered “deferred compensation”
subject to Section 409A of the Code, references in the Plan to “termination of employment” (and substantially similar
phrases) shall mean “separation from service” within the meaning of Section 409A of the Code. For purposes of Section 409A
of the Code, each of the payments that may be made in respect of any Award granted under the Plan is designated as a separate payment.

 

    21

     

    

 

(ii)               Notwithstanding
anything in the Plan to the contrary, if the Participant is a “specified employee” within the meaning of
Section 409A(a)(2)(B)(i) of the Code, no payments or deliveries in respect of any Awards that are “deferred
compensation” subject to Section 409A of the Code shall be made to such Participant prior to the date that is six months
after the date of such Participant’s “separation from service” within the meaning of Section 409A of the Code
or, if earlier, the Participant’s date of death. All such delayed payments or deliveries will be paid or delivered (without
interest) in a single lump sum on the earliest date permitted under Section 409A of the Code that is also a business day.

 

(iii)             
In the event that the timing of payments in respect of any Award that would otherwise be considered “deferred compensation”
subject to Section 409A of the Code would be accelerated upon the occurrence of (A) a Change in Control, no such acceleration
shall be permitted unless the event giving rise to the Change in Control satisfies the definition of a change in the ownership or effective
control of a corporation, or a change in the ownership of a substantial portion of the assets of a corporation pursuant to Section 409A
of the Code and any Treasury Regulations promulgated thereunder, or (B) a Disability, no such acceleration shall be permitted unless
the Disability also satisfies the definition of “disability” pursuant to Section 409A of the Code and any Treasury Regulations
promulgated thereunder.

 

(u)          
Clawback; Forfeiture; Detrimental Conduct.

 

(i)                The
Committee shall have full authority to implement any policies and procedures necessary to comply with Section 10D of the Exchange
Act and any rules promulgated thereunder and any other regulatory regimes. Notwithstanding anything to the contrary contained herein,
the Committee may, to the extent permitted by applicable law and stock exchange rules or by any applicable Company policy or arrangement,
and shall, to the extent required, cancel or require reimbursement of any Awards granted to the Participant or any Shares issued or cash
received upon vesting, exercise or settlement of any such Awards or sale of Shares underlying such Awards. By accepting an Award, the
Participant agrees that the Participant is subject to any clawback policies of the Company in effect from time to time.

 

(ii)               Except
as otherwise determined by the Committee, notwithstanding any other term or condition of the Plan, if a Participant engages in Detrimental
Conduct, whether during the Participant’s service with the Company or an Affiliate or after the Participant’s termination
of service with the Company or an Affiliate, in addition to any other penalties or restrictions that may apply under the Plan, applicable
law, or otherwise, the Participant must forfeit or pay to the Company the following: (i) any and all outstanding Awards granted to the
Participant, including Awards that have become vested or exercisable; (ii) any cash or Shares received by the Participant in connection
with the Plan within the 36-month period immediately before the date the Company determines the Participant has engaged in Detrimental
Conduct; and (iii) the profit realized by the Participant from the sale, or other disposition for consideration, of any Shares received
by the Participant under the Plan within the 36-month period immediately before the date the Company determines the Participant has engaged
in Detrimental Conduct.

 

(v)          
No Representations or Covenants with Respect to Tax Qualification. Although the Company may endeavor to (i) qualify
an Award for favorable U.S. or non-U.S. tax treatment or (ii) avoid adverse tax treatment, the Company makes no representation to
that effect and expressly disavows any covenant to maintain favorable or avoid unfavorable tax treatment. The Company shall be unconstrained
in its corporate activities without regard to the potential negative tax impact on holders of Awards under the Plan.

 

    22

     

    

 

(w)           No
Interference. The existence of the Plan, any Award Agreement and the Awards granted hereunder shall not affect or restrict in
any way the right or power of the Company, the Board, the Committee or the stockholders of the Company to make or authorize any
adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, any merger or
consolidation of the Company, any issue of stock or of options, warrants, or rights to purchase stock or of bonds, debentures, or
preferred or prior preference stocks whose rights are superior to or affect the Shares or the rights thereof or that are convertible
into or exchangeable for Shares, or the dissolution or liquidation of the Company or any Affiliate, or any sale or transfer of all
or any part of their assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.

 

(x)           
Expenses; Titles and Headings. The expenses of administering the Plan shall be borne by the Company and its Affiliates.
The titles and headings of the sections in the Plan are for convenience of reference only, and, in the event of any conflict, the text
of the Plan, rather than such titles or headings, shall control.

 

(y)          
Whistleblower Acknowledgments. Notwithstanding anything to the contrary herein, nothing in this Plan or any Award Agreement
will (i) prohibit a Participant from making reports of possible violations of federal law or regulation to any governmental agency
or entity in accordance with the provisions of and rules promulgated under Section 21F of the Exchange Act or Section 806 of
the Sarbanes-Oxley Act of 2002, or of any other whistleblower protection provisions of federal law or regulation, or (ii) require
prior approval by the Company or any of its Affiliates of any reporting described in clause (i).

 

(z)           
Lock-Up Agreements. The Committee may require a Participant receiving Shares pursuant to the Plan, as a condition precedent
to receipt of such Shares, to enter into a shareholder agreement or “lock-up” agreement in such form as the Committee shall
determine is necessary or desirable to further the Company’s interests.

 

(aa)        
Restrictive Covenants. The Committee may impose restrictions on any Award with respect to non-competition, non-solicitation,
non-disparagement, non-disclosure of confidential information and other restrictive covenants as it deems necessary or appropriate in
its sole discretion.

 

*        *        *

 

As adopted by the Board of Directors of the Company
on May 13, 2021.

 

As approved by the stockholders of the Company
on May 13, 2021.

 

    23Document

Exhibit 10.1

THIRD AMENDMENT

TO
LICENSE AGREEMENT

This amendment (“Third Amendment”) to Agreement (defined below) is entered into by and between Sunovion Pharmaceuticals Inc. (formerly Cynapsus Therapeutics, Inc.) (“Sunovion”) and Aquestive Therapeutics, Inc. (formerly MonoSol Rx, LLC) (“Aquestive”) and is effective as of July 23, 2021 (the “Third Amendment Effective Date”). Capitalized terms not defined herein shall have the meaning set forth in the Agreement. Except as set forth in this Third Amendment, all other terms and conditions of the Agreement shall remain in full force and effect.

RECITALS

WHEREAS, Cynapsus Therapeutics, Inc. developed and owned patented technology related to the film-based drug delivery of the active pharmaceutical ingredient, Apomorphine;

WHEREAS, Aquestive Therapeutics, Inc. owns patented and trade secret proprietary technology related to film-based drug delivery systems which includes orally soluble film strips containing active pharmaceutical ingredients;

WHEREAS, under the Agreement, Cynapsus Therapeutics, Inc. obtained an exclusive right and license from Aquestive Therapeutics, Inc. in connection with the development and commercialization of Apomorphine for oral administration (the “Product”);

WHEREAS, Sunovion acquired Cynapsus Therapeutics, Inc. and all rights and licenses to its technology in October of 2016;

WHEREAS, the Parties to this Third Amendment wish to amend certain terms of that certain License Agreement (as amended) entered into by and between the Sunovion and Aquestive effective as of April 1, 2016 (the “Agreement”) to clarify the definition of the Field and certain sublicense rights and obligations of the Parties under the Agreement, as outlined below;

NOW, THEREFORE, the Parties agree as follows:

1.    Section 1.1.25 is deleted in its entirety and replaced with the following:

“1.1.25 "Field" means the indications in humans of: (a) the acute, intermittent treatment of hypomobility, "off' episodes associated with Parkinson's disease in patients that have motor fluctuations; (b) restless leg syndrome; (c) erectile dysfunction; and (d) treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral anti-Parkinson medication”

2.    Section 2.1.3 is deleted in its entirety and replaced with the following:

“Licensee shall have the right to sublicense the license rights set forth in this Section 2.1    to any Affiliate and to a Third Party subject to Licensor's prior written consent, which will not be unreasonably withheld. Notwithstanding the foregoing, the Licensee shall have the right to subcontract (and grant related sublicenses) for the manufacture of the Products with up to two (2) Third Parties (at any one time) without Licensor's prior written consent. Upon request, Licensee shall provide the names of the subcontract manufacturers to Licensor.

Licensee will be responsible for the performance and obligations of the sublicensee party under the Sublicense (the “Sublicensee Party”) and any and all other sublicensees subsequently granted a sublicense under and in accordance with the terms and conditions of the Sublicense by the Sublicensee Party (such sublicensees, collectively with the Sublicensee Party, referred to herein as the “Sublicensees”). Licensor will not be liable to Sublicensees for any matter in respect of, and will not be required to participate in, any challenges or disputes between Licensee and any Sublicensees under the Sublicense Agreement or otherwise and that 

nothing contained in this Agreement, express or implied, is intended to be or shall be, for the benefit of or enforceable by any Sublicensees, and Sublicensees shall not obtain any right as a third-party beneficiary under the this Agreement including, without limitation, any right to make any claim in respect of any debt, liability or obligation under this Agreement or otherwise against Licensor. Licensor and Licensee acknowledge and agree that Licensee may share a copy of this Agreement, and any amendments thereof, with the Sublicensees, and that Licensor may share a copy of Quarterly Royalty Reports and reports of any audits performed pursuant to the Agreement, or other reports or documents relating to Payments, with Licensor’s assignee of royalties and other amounts due to Licensor under the Agreement, subject to the provisions of confidentiality set forth herein.”

3.    The following shall be added after Section 7.4.5:

“7.4.5.1 Survival of Europe Sublicenses. Upon termination of this Agreement for any reason, upon the written request of any Sublicensee Party based in Europe (“Europe Sublicensee”) not then in breach of its sublicense agreement or the terms of this Agreement applicable to such Europe Sublicensee, Licensor will enter into a direct license from Licensor to such Europe Sublicensee on substantially the same terms as this Agreement, including without limitation all obligations of Licensee under this Agreement, taking into account any difference in license scope, the Europe Sublicensee Territory (as hereinafter defined) and duration of sublicense grant between the applicable sublicensee agreement with the Europe Sublicensee and this Agreement (each a “New License Agreement”). The Europe Sublicensee Territory shall be defined as all member states of the European Union (“EU”) and the European Economic Area (“EEA”) including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lichtenstein, Lithuania, Luxemburg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and United Kingdom and any new member state of the EU and EEA shall automatically become part of the Europe Sublicensee Territory. Any member state of the EU and EEA which withdraws from the EU and/or EEA, as applicable, will remain part of the Europe Sublicensee Territory. Under any such New License Agreement between Licensor and Europe Sublicensee , the Europe Sublicensee will be required to pay to Licensor the same amounts in consideration for such direct grant as Licensor would have otherwise received from Licensee pursuant to this Agreement on account of such Europe Sublicensee’s sales of the Products had this Agreement not been terminated. Under such New License Agreement, the Parties agree that Licensor will not be bound by any grant of rights broader than, and will not be required to perform any obligation other than those rights and obligations contained in, this Agreement, and all applicable rights of Licensor set forth in this Agreement will be included in such New License Agreement.”

[Signatures to follow on next page.]

IN WITNESS WHEREOF, the Parties hereto have caused this Third Amendment to be executed by their duly authorized representatives to be effective as of the Third Amendment Effective Date stated above.

															
	Sunovion Pharmaceuticals Inc.
		Aquestive Therapeutics, Inc.

					
	By:	 /s/ Yumi Sato		By:     	 /s/ Lori Braender
	Print Name:	 Yumi Sato		Print Name:: 	Lori Braender
	Title: 	EVP, Chief Corporate Strategy Officer		Title
	SVP, General Counsel

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]